Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pandemic H1N1 influenza vaccination cohort study in patients with cystic fibrosis
2009-016662-90Phase 4Completed
- Sponsor
- Inserm
- Start
- Oct 2009
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza A (H1N1) vaccine in influenza A virus infection (H1N1) (2 cohorts), sponsored by Inserm. Primary endpoints: Incidence of influenza A (H1N1) in vaccinated versus non-vaccinated patients and Clinical effectiveness of pandemic H1N1 vaccination. Started Oct 2009; status: completed.
02
Drugs
influenza A (H1N1) vaccine
03
Conditions
influenza A virus infection (H1N1)
Beyond the preview
Go deeper on 2009-016662-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016662-90.